Biotech · Public company · Bethesda, MD, US
Northwest Biotherapeutics Inc
Ticker NWBO · SEC CIK 0001072379
Track this companyFree. Adds Northwest Biotherapeutics Inc to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline1
- Dendritic cell immunotherapyPhase 3 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian CancerPHASE2 · NOT_YET_RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07634094 · fetched Nov 12, 2026
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain CancerPHASE3 · UNKNOWN · started Dec 1, 2006ClinicalTrials.gov NCT00045968 · fetched Nov 12, 2026
SEC filings12
- 8-K · FORM 8-KSEC EDGAR · filed Oct 30, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 14, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 31, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 20, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 15, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Apr 15, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Apr 7, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jan 15, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jan 2, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Nov 20, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 14, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Oct 31, 2025 · fetched Nov 12, 2026